<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of this study was to examine the protective effects of an <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, MK-801, and <z:chebi fb="0" ids="7983">pentobarbital</z:chebi> against neuronal damage in a global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> model under controlled body temperature </plain></SENT>
<SENT sid="1" pm="."><plain>Gerbils were subjected to 3 and 5 min of bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>MK-801 (1 and 5 mg/kg, i.p.), administered 30 min before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, significantly attenuated the degeneration of hippocampal CA1 pyramidal cells after 3 min of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in a dose dependent manner, but had no such effects after 5 min of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="7983">Pentobarbital</z:chebi> (40 mg/kg, i.p.) also protected against CA1 damage after 3 min of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> but not after 5 min of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, we confirmed the protective effects of these agents under normothermic conditions, although these effects were limited to shorter periods of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>